Riskpilot← Back to searchSign inGet full accessMEDI-COS ApS
APSActiveCVR 21774383Gasværksvej 15, 2. thWholesale of pharmaceutical and medical goods · NACE 4646Est. 1999— employeesforzetsport.dk
Revenue 2025
DKK -20K
-151% vs 2024
EBITDA margin
100.0%
-151% vs 2024
Equity ratio
-3213.3%
Financial strength
Net profit 2025
DKK -20K
-151% vs 2024
| Revenue | DKK -20K | -151% |
| EBITDA | DKK -20K | -151% |
| Net profit | DKK -20K | -151% |
| Total assets | DKK 4K | -97% |
| Equity | DKK -123K | -20% |
| Employees | — | — |
Legal name
MEDI-COS ApS
CVR number
21774383
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
15. juni 1999
Share capital
DKK 175.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive engros handel, fortrinsvis med medicinvarer, næringsmidler, plastre og forbindingsstoffer, sygeplejeartikler, kosmetiske præparater, parfumerivarer og toiletartikler.
Address
Gasværksvej 15, 2. th
Phone
+4520187913
Email
info@forzetsport.com
Website
forzetsport.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 192 | 190 | 145 | 135 | 152 | 173 | 109 | 110 | 18 | -60 | -97 | -41 | 39 | -20 |
| Staff expenses | -0 | -0 | -0 | -0 | -2 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -19 | -11 | -31 | 5 | 10 | -12 | -9 | 13 | 18 | -60 | -97 | -41 | 39 | -20 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -5 | -0 | -0 | -0 | -0 |
| EBIT | -19 | -11 | -31 | 5 | 10 | -12 | -9 | 13 | 18 | -65 | -97 | -41 | 39 | -20 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -19 | -11 | -31 | 5 | 10 | -12 | -9 | 13 | 18 | -65 | -97 | -41 | 39 | -20 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -19 | -11 | -31 | 5 | 10 | -12 | -9 | 13 | 18 | -65 | -97 | -41 | 39 | -20 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 112 | 98 | 55 | 51 | 61 | 47 | 42 | 60 | 74 | 203 | 152 | 78 | 117 | 4 |
| Equity | 78 | 68 | 36 | 42 | 52 | 40 | 31 | 44 | 61 | -4 | -101 | -142 | -103 | -123 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 33 | 30 | 19 | 9 | 9 | 6 | 11 | 16 | 12 | 207 | 253 | 220 | 220 | 127 |
| Total debt | 33 | 30 | 19 | 9 | 9 | 6 | 11 | 16 | 12 | 207 | 253 | 220 | 220 | 127 |
EBITDA margin
-2018600.0%
This company
15.8%
Market median
-12776049% vs market
20122025
Equity ratio
-3213.3%
This company
38.2%
Market median
-8512% vs market
20122025
Return on equity
-2018600.0%
This company
18.4%
Market median
-10970752% vs market
20122025
Net profit margin
-2018600.0%
This company
8.1%
Market median
-24921088% vs market
20122025
Asset turnover
-5.28×
This company
1.12×
Market median
-571% vs market
20122025
Debt / equity
1.03×
This company
0.62×
Market median
-66% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EK Founder | Founder | 1999 | — | — |
CH Management | Management | 1999 | — | — |
AB Audit | Audit | 2002 | — | — |
MO Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
PD Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
JK Management | Management | 1999 | — | — |
CK | Founder | 1999 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
PIA & CLAUS DINESEN HOLDING ApS | Company | 50.0% | 50.0% | 2020 |
Marc Lorentzen Holding ApS | Company | 20.0% | 20.0% | 2021 |
Magnus Dinesen Holding ApS | Company | 20.0% | 20.0% | 2021 |
| Individual | 25.0% | 25.0% | 1999 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PIA & CLAUS DINESEN HOLDING ApS
MEDI-COS ApS Board members of MEDI-COS ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Kjærulf Bokkenheuser | Founder | 0 companies |
| Carl Henrik Bokkenheuser | Management | 0 companies |
| Arne Bang | Audit | 0 companies |
| Magnus Oliver Lorentzen Dinesen | Chief Executive Officer | 0 companies |
| Pia Dinesen | Chief Executive Officer | 0 companies |
| Jette Kjærulf Bokkenheuser | Management | 0 companies |
| Christian Kjærulf Bokkenheuser | Founder | 0 companies |
| Marc Phillip Gall Schultz Lorentzen | Chairman | 0 companies |